IL6 and Alzheimer disease: Whether a resulting enhanced IL-6 sensitivity upon BACE inhibition contributes to the adverse events of BACE inhibitors remains unknown, but increased, pro-inflammatory IL-6 signaling is linked to cognitive decline in AD [107].